Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

518 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Endothelial progenitor cells contribute to accelerated liver regeneration.
Beaudry P, Hida Y, Udagawa T, Alwayn IP, Greene AK, Arsenault D, Folkman J, Heymach JV, Ryeom S, Puder M. Beaudry P, et al. Among authors: heymach jv. J Pediatr Surg. 2007 Jul;42(7):1190-8. doi: 10.1016/j.jpedsurg.2007.02.034. J Pediatr Surg. 2007. PMID: 17618879
Antiangiogenic therapy and p53.
Browder T, Folkman J, Hahnfeldt P, Heymach J, Hlatky L, Kieran M, Rogers MS. Browder T, et al. Science. 2002 Jul 26;297(5581):471; discussion 471. Science. 2002. PMID: 12143876 No abstract available.
Angiogenesis inhibitors and hypoxia.
Kieran MW, Folkman J, Heymach J. Kieran MW, et al. Nat Med. 2003 Sep;9(9):1104; author reply 1104-5. doi: 10.1038/nm0903-1104a. Nat Med. 2003. PMID: 12949515 No abstract available.
Differential effects of vascular endothelial growth factor receptor-2 inhibitor ZD6474 on circulating endothelial progenitors and mature circulating endothelial cells: implications for use as a surrogate marker of antiangiogenic activity.
Beaudry P, Force J, Naumov GN, Wang A, Baker CH, Ryan A, Soker S, Johnson BE, Folkman J, Heymach JV. Beaudry P, et al. Among authors: heymach jv. Clin Cancer Res. 2005 May 1;11(9):3514-22. doi: 10.1158/1078-0432.CCR-04-2271. Clin Cancer Res. 2005. PMID: 15867254
Blood-based biomarkers of SU11248 activity and clinical outcome in patients with metastatic imatinib-resistant gastrointestinal stromal tumor.
Norden-Zfoni A, Desai J, Manola J, Beaudry P, Force J, Maki R, Folkman J, Bello C, Baum C, DePrimo SE, Shalinsky DR, Demetri GD, Heymach JV. Norden-Zfoni A, et al. Among authors: heymach jv. Clin Cancer Res. 2007 May 1;13(9):2643-50. doi: 10.1158/1078-0432.CCR-06-0919. Clin Cancer Res. 2007. PMID: 17473195 Clinical Trial.
518 results